The MiniMed 780G with the Simplera Sync CGM and accompanying devices. [Image courtesy of Medtronic] The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline ...

The Biosensors Market is growing with demand for rapid, accurate diagnostics in healthcare, food safety, and environmental monitoring, driven by advances in biotechnology.Austin, Feb. 12, 2025 (GLOBE ...

distinguished for integrating advanced technology into its CGM products. The Medtronic Guardian Connect system not only monitors glucose levels but also utilizes predictive algorithms to forewarn ...

Medtronic is hoping that their efforts in the AID and "smart dosing" markets will pay off after largely missing out on the CGM market. They may be onto something. The recent ADA guidelines do ...

Many, or all, of the products featured on this page are from our advertising partners who compensate us when you take certain actions on our website or click to take an action on their website ...

In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against other best dividend stocks to buy and hold. In recent years, many investors have shifted their focus ...

New Medtronic CFO Thierry Piéton. [Image from Mobilize Financial Services] Medtronic (NYSE: MDT) + announced today that it appointed Thierry Piéton as its new chief financial officer (CFO ...

The Medtronic Symplicty Spyral renal denervation ablation catheter expands inside the renal arteries. It ablates nerves in the vessel wall to treat hypertension. [Illustration courtesy of ...

Since the start of 2025, Medtronic plc (NYSE:MDT) has surged by nearly 10%. Earlier this year, the company secured US approval for its Simplera continuous glucose monitoring (CGM) system.